- AdventHealth
MINNEOLA, Fla. – AdventHealth broke ground today on AdventHealth Minneola, an 80-bed hospital that will bring inpatient care to the growing population of south Lake County. Leaders and community members came together to mark the start of construction.
The four-story hospital will be located on Hancock Road at Florida’s Turnpike, off the Minneola interchange. The facility will be approximately 204,000 square feet and includes an emergency department; full-service imaging; five operating suites; endoscopy services; outpatient laboratory; heart catheterization labs; 40 critical care patient rooms and 40 general medical or surgical rooms. These new services will meet a significant need in south Lake County which has seen a shortage of physicians in nearly every specialty.
As part of AdventHealth's $271 million investment in the community's health care infrastructure, AdventHealth Minneola will serve as a beacon of hope and healing. A recent study by Sg2, a health care consulting agency, estimates the population of Minneola will increase by 13% in the next five years, making the provision of high-quality acute care services critical.
“We are committed to providing convenient, whole-person care close to home, wherever consumers live in Central Florida,” said Kari Vargas, CEO of AdventHealth’s Northwest Market. “With a fast-growing population and a community need for additional access to primary and specialty care, we look forward to offering the residents of South Lake a complete range of exceptional, compassionate care.”
The Agency for Healthcare Administration (ACHA) reports that over 45% of residents of this community leave the county to receive inpatient services.
"In many cases, we know that the best medical care is care that is close to home,” said Dr. Nicholas McAlister, director of emergency medicine at AdventHealth Clermont and Winter Garden. “For many residents of this community, that care hasn't been available, which leads them to leave the area if they need hospital services. This facility will allow more of those people to receive world-class care closer to home."
The Minneola campus joins AdventHealth’s growing network of inpatient and outpatient services in the South Lake and West Orange communities. The hospital will be located in a new and up-and-coming development, as well as within walking distance of shopping, entertainment, housing, and green space.
“It is an honor for me and my fellow City Council members to welcome AdventHealth to Minneola,” said Mayor Pat Kelley. “The presence of AdventHealth in our community will further accelerate the development of our economic development zone. AdventHealth Minneola hospital will not only offer residents a health care provider to proud of, but also bring good high-paying health care jobs to our community.”
Upon completion, the hospital will bring 500 jobs to the community.
The architect is ESa and the general contractor is Brasfield & Gorrie. AdventHealth Minneola is scheduled to open in late 2025.
Recent News
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...